From: The effect of varying analytical methods on estimates of anti-malarial clinical efficacy
 | Africa | Thailand | Overall |
---|---|---|---|
ITT – mITT |  |  |  |
Unadjusted | 1.8% [-0.3–11.7] IQR: 0.7–3.9 | 11.4% [2.1–31.8]a IQR: 8.1–15.8 | 4.7% [-0.3–31.8] IQR: 1.6–10.6 |
Adjusted | 3.5% [-13.7–14.4] IQR: 0.9–6.0 | 12.3% [4.1–31.8]a IQR: 10.2–16.0 | 5.4% [-13.7–31.8] IQR: 1.9–11.6 |
PP – mITT |  |  |  |
Unadjusted | 0.1% [0.0–2.1] IQR: 0–0.23 | 1.9% [0.0–10.6]a IQR: 0.9–4.3 | 0.3% [0.0–10.6] IQR: 0.1–1.9 |
Adjusted | 3.2% [0.0–0.9] IQR: 0.7–3.9 | 1.0% [0.0–6.9]b IQR: 0.3–1.8 | 1.7% [0.0–30.9] IQR: 0.5–5.6 |